| Q28305510 | A National Cancer Clinical Trials Network: recommendations from the Institute of Medicine |
| Q39227159 | A study in contrasts: eligibility criteria in a twenty-year sample of NSABP and POG clinical trials. National Surgical Adjuvant Breast and Bowel Program. Pediatric Oncology Group |
| Q88735032 | Acute myeloid leukemia therapy and the chosen people |
| Q91106461 | Adverse events related to abiraterone and enzalutamide treatment: analysis of the EudraVigilance database and meta-analysis of registrational phase III studies |
| Q40663333 | Algorithms in the First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma--Analysis Using Diagnostic Nodes |
| Q37170627 | An institutional strategy to increase minority recruitment to therapeutic trials |
| Q41472952 | BALANCE: a large simple trial of maintenance treatment for bipolar disorder. |
| Q33836107 | Best hope or last hope: access to phase III clinical trials of HER-2/neu for advanced stage breast cancer patients |
| Q97516800 | Broadening Eligibility Criteria for Oncology Clinical Trials: Current Advances and Future Directions |
| Q48088530 | Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement. |
| Q36685525 | CSIOVDB: a microarray gene expression database of epithelial ovarian cancer subtype |
| Q44247120 | Can we conduct some large simple trials in bipolar disorder? |
| Q33503382 | Chemotherapy with cisplatin and teniposide for cerebral metastases in non-small cell lung cancer |
| Q34498710 | Clinical trials in crisis: Four simple methodologic fixes |
| Q47247699 | Clinical trials in the genomic era: effects of protective genotypes on sample size and duration of trial |
| Q37029899 | Comorbidity in older adults with cancer. |
| Q37696455 | Comparison of survival outcomes among cancer patients treated in and out of clinical trials |
| Q38123385 | Eligibility criteria in knee osteoarthritis clinical trials: systematic review |
| Q37228507 | Feasibility of feature-based indexing, clustering, and search of clinical trials. A case study of breast cancer trials from ClinicalTrials.gov |
| Q36176911 | From evidence to clinical practice in blood and marrow transplantation |
| Q37040827 | Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer |
| Q50158082 | Guidelines for quality assurance in multicenter trials: a position paper |
| Q79134557 | High time for low‐dose prospective clinical trials |
| Q31110231 | How Well Do Randomized Controlled Trials Reflect Standard Care: A Comparison between Scientific Research Data and Standard Care Data in Patients with Intermittent Claudication undergoing Supervised Exercise Therapy. |
| Q39643826 | Inclusion of elderly patients in oncology clinical trials. |
| Q90010770 | Inclusiveness and ethical considerations for observational, translational, and clinical cancer health disparity research |
| Q33861570 | Integration of geriatrics in oncology training--the relationship between the academic center and the community |
| Q97522269 | Olaparib Outcomes in Patients with BRCA 1-2 Mutated, Platinum-Sensitive, Recurrent Ovarian Cancer in Croatia: A Retrospective Noninterventional Study |
| Q49623381 | Patient and family member perspectives on searching for cancer clinical trials: A qualitative interview study |
| Q35810590 | Patient and physician factors associated with participation in cervical and uterine cancer trials: an NRG/GOG247 study |
| Q90446343 | Patterns of care in metastatic pancreatic cancer: patient selection in clinical routine |
| Q35214733 | Quality assurance in clinical trials |
| Q47550272 | Re-Evaluating Eligibility Criteria for Oncology Clinical Trials: Analysis of Investigational New Drug Applications in 2015. |
| Q55712411 | Recruitment practices for U.S. minority and underserved populations in NRG oncology: Results of an online survey☆. |
| Q50725436 | Statistical issues in the validation of prognostic, predictive, and surrogate biomarkers. |
| Q48476773 | Survival and functional status after resection of recurrent glioblastoma multiforme |
| Q33706196 | Techniques for health economics analysis in oncology: Part 2. |
| Q36834305 | The problems and promise of central pathology review: development of a standardized procedure for the Children's Oncology Group |
| Q47609603 | The relationship between eligibility criteria and adverse events in randomized controlled trials of hematologic malignancies |
| Q47653011 | The representativeness of eligible patients in type 2 diabetes trials: a case study using GIST 2.0. |
| Q43863224 | Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials. |
| Q45949689 | Use of crowdsourcing for cancer clinical trial development. |
| Q38970750 | Use of negative pressure wound therapy on malignant wounds - a case report and review of literature |